Specialized Device Inspectorate Part Of Joint CDRH/ORA Action Plan
This article was originally published in The Silver Sheet
FDA’s Office of Regulatory Affairs will establish a specialized unit of device-focused field investigators according to a 2015 CDRH/ORA program alignment action plan posted online Oct. 7. Under the announced steps, CDRH will work with ORA throughout the current fiscal year to develop a plan for establishing a medical device inspectorate and a separate mammography quality inspectorate.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.